Pharmacokinetic Studies of Gel System Containing Ibuprofen Solid Nanoparticles
Tóm tắt
Từ khóa
Tài liệu tham khảo
1) Ulbrich, H.; Dannhardt, G. A heterogenous drug class, NSAID: classification and spectrum of action. Pharm. Unserer Zeit 31, 146-154 (2002).
2) Yong, C.S.; Oh, Y.K.; Jung, S.H.; Rhee, J.D.; Kim, H.D.; Kim, C.K.; Choi, H.G. Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol. Eur. J. Pharm. Sci. 23, 347-353 (2004).
3) Newa, M.; Bhandari, K.H.; Li, D.X.; Kwon, T.H.; Kim, J.A.; Yoo, B.K.; Woo, J.S.; Lyoo, W.S.; Yong, C.S.; Choi, H.G. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int. J. Pharm. 343, 228-237 (2007).
4) Glowka, F.K. Stereoselective pharmacokinetics of ibuprofen and its lysinate from suppositories in rabbits. Int. J. Pharm. 199, 159-166 (2000).
5) Ghorab, M.K.; Adeyeye, M.C. Enhancement of ibuprofen dissolution via wet granulation with betacyclodextrin. Pharm. Dev. Technol. 6, 305-314 (2001).
6) Maghsoodi, M.; Kiafar, F. Co-precipitation with PVP and agar to improve physicomechanical properties of ibuprofen. Iran J. Basic Med. Sci. 16, 635-642 (2013).
7) Ji, H.Y.; Lee, H.W.; Kim, Y.H.; Jeong, D.W.; Lee, H.S. Simultaneous determination of piroxicam, Meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry. J. Chromatogr B Analyt. Technol. Biomed Life Sci. 826, 214-219 (2005).
8) Gupta, S.K.; Bansal, P.; Bhardwaj, R.K.; Jaiswal, J.; Velpandian, T. Comparison of analgesic and antiinflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application. Skin Pharmacol. Appl. Skin Physiol. 15, 105-111 (2002).
9) Patel, A.; Bell, M.; O’Connor, C.; Inchley, A.; Wibawa, J.; Lane, M.E. Delivery of ibuprofen to the skin. Int. J. Pharm. 457, 9-13 (2013).
10) Abdel-Mottaleb, M.M.; Neumann, D.; Lamprecht, A. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Eur. J. Pharm. Biopharm. 79, 36-42 (2011).
11) Nagai, N.; Ito, Y. Therapeutic effects of gel ointments containing tranilast nanoparticles on paw edema in adjuvant-induced arthritis rats. Biol. Pharm. Bull. 37, 96-104 (2014).
12) Nagai, N.; Yoshioka, C.; Ito, Y. Topical therapies for rheumatoid arthritis by gel ointments containing indomethacin nanoparticles in adjuvant-induced arthritis rat. J. Oleo Sci. 64, 337-346 (2015).
13) Nagai, N.; Iwamae, A.; Tanimoto, S.; Yoshioka, C.; Ito, Y. Pharmacokinetics and antiinflammatory effect of a novel gel system containing ketoprofen solid nanoparticles. Biol. Pharm. Bull. 38, 1918-1924 (2015).
14) Cohen, S.; Yoshioka, T.; Lucarelli, M.; Hwang, L.H.; Langer, R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8, 713-720 (1991).
15) Tomoda, K.; Terashima, H.; Suzuki, K.; Inagi, T.; Terada, H.; Makino, K. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf. B. Biointerfaces 88, 706-710 (2011).
16) Tomoda, K.; Terashima, H.; Suzuki, K.; Inagi, T.; Terada, H.; Makino, K. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo. Colloids Surf. B. Biointerfaces 92, 50-54 (2012).
17) Tomoda, K.; Watanabe, A.; Suzuki, K.; Inagi, T.; Terada, H.; Makino, K. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf. B. Biointerfaces 97, 84-89 (2012).
18) Nagai, N.; Yoshioka, C.; Mano, Y.; Tnabe, W.; Ito, Y.; Okamoto, N.; Shimomura, Y. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure. Exp. Eye Res. 132, 115-123 (2015).
19) Nagai, N.; Ito, Y. Effect of Solid Nanoparticle of Indomethacin on Therapy for Rheumatoid Arthritis in Adjuvant-Induced Arthritis Rat. Biol. Pharm. Bull. 37, 1109-1118 (2014).
20) Nagai, N.; Ito, Y.; Okamoto, N.; Shimomura, Y. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. Toxicology 319, 53-62 (2014).
21) Nagai, N.; Ono, H.; Hashino, M.; Ito, Y.; Okamoto, N.; Shimomura, Y. Improved corneal toxicity and permeability of tranilast by the preparation of ophthalmic formulations containing its nanoparticles J. Oleo Sci. 63, 177-186 (2014).
22) Yamaoka, K.; Tanigawara, Y.; Nakagawa, T.; Uno, T. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobiodyn. 4, 879-885 (1981).
23) Ito, Y.; Ogiso, T.; Iwaki, M.; Tanino, T.; Terao, M. Percutaneous absorption of acemetacin from a membrane controlled transdermal system and prediction of the disposition of the drug in rats. Biol. Pharm. Bull. 16, 583-588 (1993).
24) Billingham, M.E. Models of arthritis and the search for anti-arthritic drugs. Pharmacol. Ther. 21, 389-428 (1983).
25) Sakuma, S.; Nishigaki, F.; Magari, K.; Ogawa, T.; Miyata, S.; Ohkubo, Y.; Goto, T. FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis. Inflamm. Res. 50, 509-514 (2001).
26) Kato, S.; Takeuchi, K. Alteration of gastric ulcerogenic and healing responses in rats with adjuvant-induced arthritis. Jpn. J. Pharmacol. 89, 1-6 (2002).
27) Kato, S. Changes in ulcerogenic response to non-steroidal anti-inflammatory drugs (NSAIDs) in adjuvant arthritic rats. Yakugaku Zasshi 121, 743-751 (2001).